Trial Profile
Open label, multicentre study, evaluating the safety, tolerability, efficacy, compliance and the acceptability of alkalising treatments at long-term in patients with cystinuria
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II/III
Latest Information Update: 15 Mar 2024
Price :
$35
*
At a glance
- Drugs Potassium bicarbonate/potassium citrate (Primary) ; Potassium bicarbonate; Potassium citrate; Sodium bicarbonate; Sodium citrate
- Indications Cystinuria
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Advicenne
- 08 Mar 2024 Planned End Date changed from 1 Aug 2022 to 1 Aug 2025.
- 08 Mar 2024 Planned primary completion date changed from 1 Aug 2022 to 1 Jun 2025.
- 08 Mar 2024 Planned initiation date changed to 1 May 2024.